Abnormal cytoskeletal protein expression in cultured skin fibroblasts from type 1 diabetes mellitus patients with nephropathy: A proteomic approach

Proteomics - Clinical Applications

Volumn 2, Issue 4, 2008, Pages 492-503

  Millioni, Renato ^a   Iori, Elisabetta ^a   Puricelli, Lucia ^a   Arrigon, Giorgio ^a,b   Vedovato, Monica ^a   Trevisan, Roberto ^a,c   James, Peter ^b   Tiengo, Antonio ^a   Tessari, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Protein Technology Wallenberglab   (Sweden)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

Cytoskeletal proteins; Diabetic nephropathy; Fibroblasts

Indexed keywords

ALPHA 3 TROPOMYOSIN; ALPHA 4 TROPOMYOSIN; ALPHA ACTININ; ALPHA ACTININ 4; ALPHA TROPOMYOSIN; BETA 1 TROPOMYOSIN; BETA 2 TUBULIN; BETA 4 TUBULIN; BETA ACTIN; BETA TUBULIN; CALDESMON; CALPONIN; CALPONIN 2; COFILIN 1; CYTOSKELETON PROTEIN; F ACTIN; F ACTIN ALPHA 1; F ACTIN BETA; ISOPROTEIN; LIM AND SH3 DOMAIN PROTEIN 1; LIM PROTEIN; MOESIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; PROTEIN SH3; TRANSGELIN; TROPOMODULIN; TROPOMODULIN 3; TROPOMYOSIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC REGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; SKIN FIBROBLAST; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 42449085888     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780112     Document Type: Article

References (54)

1. Rossing, P., The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia 2005, 48, 1439-1444.
2. Valmadrid, C. T., Klein, R., Moss, S. E., Klein, B. E., The risk of cardiovascular disease mortality associated with micro-albuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 2000, 160, 1093-1100.
3. Steffes, M. W., Bilous, R. W., Sutherland, D. E., Mauer, S. M., Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 1992, 41, 679-684.
4. Østerby, R., Parving, H. H., Nyberg, G., Hommel, E. et al., A strong positive correlation between glomerular filtration rate and filtration surface in diabetic nephropathy. Diabetologia 1988, 31, 265-270.
5. Mauer, M., Fioretto, P., Woredekal, Y., Friedman, E. A., Diabetic nephropathy, in: Schrier, R. W. (Ed.), Diseases of the Kidney, Lippincott Williams & Wilkins, Philadelphia 2001.
6. Brito, P. L., Fioretto, P., Drummond, K., Kim, Y. et al., Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int. 1998, 53, 754-761.
7. Lane, P. H., Steffes, M. W., Fioretto, P., Mauer, S. M., Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int. 1993, 43, 661-667.
8. Fioretto, P., Steffes, M. W., Mauer, M., Glomerular structure in nonproteinuric insulin-dependent diabetic patients with various levels of albuminuria. Diabetes 1994, 43, 1358-1364.
9. Steffes, M. W., Bilous, R. W., Sutherland, D. E., Mauer, S. M., Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 1992, 41, 679-684.
10. Hovind, P., Tarnow, L., Rossing, P., Jensen, B. R. et al., Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ 2004, 328, 1105-1108.
11. Quinn, M., Angelico, M. C., Warram, J. H., Krolewski, A. S., Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996, 39, 940-945.
12. Trevisan, R., Fioretto, P., Barbosa, J., Mauer, M., Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int. 1999, 55, 2383-2389.
13. LaPointe, M. S., Batlle, D., Cultured skin fibroblasts as an in vitro model to assess phenotypic features in subjects with diabetic nephropathy. Am. J. Kidney Dis. 2001, 38, 646-648.
14. Trevisan, R., Li, L. K., Messent, J., Tariq, T. et al., Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 1992, 41, 1239-1246.
15. Lurbe, A., Fioretto, P., Mauer, M., LaPointe, M. S., Batlle, D., Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter. Kidney Int. 1996, 50, 1684-1693.
16. Iori, E., Marescotti, M. C., Vedovato, M., Ceolotto, G. et al., In situ protein kinase C activity is increased in cultured fibroblasts from type 1 diabetic patients with nephropathy. Diabetologia 2003, 46, 524-530.
17. Podestà, F., Meregalli, G., Ghepardi, R., Del Giudice, R. et al., Low Ca2+ pump activity in diabetic nephropathy. Am. J. Kidney Dis. 2001, 38, 465-472.
18. Clarkson, M. R., Murphy, M., Gupta, S., Lambe, T. et al., High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly. J. Biol. Chem. 2002, 277, 9707-9712.
19. Conway, B. R., Maxwell, A. P., Savage, D. A., Patterson, C. C. et al., Association between variation in the actin-binding gene caldesmon and diabetic nephropathy in type 1 diabetes. Diabetes 2004, 53, 1162-1165.
20. Sanai, T., Sobka, T., Johnson, T., el-Essawy, M. et al., Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia 2000, 43, 91-100.
21. Shimoni, Y., Rattner, J. B., Type 1 diabetes leads to cytoskeleton changes that are reflected in insulin action on rat cardiac K(+) currents. Am. J. Physiol. 2001, 281, E575-E585.
22. Patel, K., Harding, P., Haney, L. B., Glass, W. F.,II, Regulation of the mesangial cell myofibroblast phenotype by actin polymerization. J. Cell. Physiol. 2003, 195, 435-445.
23. Kaplan, J. M., Kim, S. H., North, K. N., Rennke, H. et al., Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 2000, 24, 251-256.
24. Johnson, R. J., Iida, H., Alpers, C. E., Majesky, M. W. et al., Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin as a marker of mesangial cell proliferation. J. Clin. Invest. 1991, 87, 847-858.
25. Tessari, P., Puricelli, L., Iori, E., Arrigoni, G. et al., Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy. J. Proteome Res. 2007, 6, 976-86.
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
27. Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S., Mische, S. M., Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20, 601-605.
28. Lerh, S., Kotzka, J., Knebel, B., Schiller, M., Primary skin fibroblasts as human model system for proteome analysis. Proteomics 2002, 2, 280-287.
29. Puricelli, L., Iori, E., Millioni, R., Arrigoni, G. et al., Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J. Clin. Endocrinol. Metab. 2006, 91, 3507-3514.
30. Cooper, J., A., The role of actin polymerization in cell mobility. Annu. Rev. Physiol. 1991, 53, 585-605.
31. Theriot, J. A., Mitchison, T. J., Actin microfilament dynamics in locomoting cells. Nature 1991, 352, 126-131.
32. Scott, J. N., Clark, A. W., Zochodne, D. W., Neurofilament and tubulin gene expression in progressive experimental diabetes: Failure of synthesis and export by sensory neurons. Brain 1999, 122, 2109-2118.
33. El Nahas, A. M., Muchaneta-Kubara, E. C., Zhang, G., Adam, A., Goumenos, D., Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int. Suppl. 1996, 54, S23-27.
34. Stossel, T. P., On the crawling of animal cells. Science 1993, 260, 1086-1094.
35. Bamburg, J. R., Bray, D., Distribution and cellular localization of actin depolymerization factor. J. Cell. Biol. 1987, 105, 2817-2825.
36. Sun, H. O., Kwiatkowska, K., Yin, H. L., Actin monomer binding proteins. Curr. Opin. Cell. Biol. 1995, 7, 102-110.
37. Helfman, D. M., Levy, E. T., Berthier, C., Shtutman, M. et al., Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. Mol. Biol. Cell. 1999, 10, 3097-3112.
38. Weller, P. A., Ogryzko, E. P., Corben, E. B., Zhidkova, N. I. et al., Complete sequence of human vinculin and assignment of the gene to chromosome 10. Proc. Nat. Acad. Sci. 1990, 87, 5667-5671.
39. Bretscher, A., Edwards, K., Fehon, R. G., ERM proteins and merlin: Integrators at the cell cortex. Nat. Rev. Mol. Cell. Biol. 2002, 3, 586-599.
40. Schreiber, V., Masson, R., Linares, J. L., Mattel, M. G., Chromosomal assignment and expression pattern of the murine Lasp-1 gene. Gene 1998, 207, 171-175.
41. Dandapani, S. V., Sugimoto, H., Matthews, B. D., Kolb, R. J. et al., Alpha-actinin-4 is required for normal podocyte adhesion. J. Biol. Chem. 2007 282, 467-77.
42. Yamashiro, S., Chern, H., Yamakita, Y., Matsumura, F., Mutant caldesmon lacking cdc2 phospho-rylation sites delays M-phase entry and inhibits cytokinesis. Mol. Biol. Cell. 2001, 12, 239-250.
43. Matsumura, F., Yamashiro, S., Caldesmon. Curr. Opin. Cell. Biol. 1993, 5, 70-76.
44. Tsukita, S., Yonemura, S., Cortical actin organization: Lessons from ERM (ezrin/radixin/moesin) proteins. J. Biol. Chem. 1999, 274, 34507-34510.
45. McRobert, E. A., Gallicchio, M., Jerums, G., Cooper, M. E., Bach, L. A., The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications. J. Biol. Chem. 2003, 278, 25783-25789.
46. Lee, J. H., Chung, K. Y., Bang, D., Lee, K. H., Searching for aging-related proteins in human dermal microvascular endothelial cells treated with anti-aging agents. Proteomics 2006, 6, 1351-61.
47. Morocutti, A., Earle, K. A., Sethi, M., Piras, G. et al., Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease. Kidney Int. 1996, 50, 250-256.
48. Fowler, V. M., Sussmann, M. A., Miller, P. G., Flucher, B. E., Daniels, M. P., Tropomodulin is associated with the free (pointed) ends of the thin filaments in rat skeletal muscle. J. Cell. Biol. 1993, 120, 411-420.
49. Sung, L. A., Fan, Y., Lin, C. C., Gene assignment, expression, and homology of human tropomodulin, Genomics 1996, 34, 92-96.
50. Southwick, F. S., DiNubile, M. J., Rabbit alveolar macrophages contain a Ca2+-sensitive, 41,000-dalton protein which reversibly blocks the "barbed" ends of actin filaments but does not sever them. J. Biol. Chem. 1986, 261, 14191-14195.
51. Trevisan, R., Yip, J., Sarika, L., Li, L. K., Viberti, G. J., Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. Am. Soc. Nephrol. 1997, 8, 1133-1139.
52. Yip, J., Mattock, M. B., Morocutti, A., Sethi, M. et al., Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993, 342, 883-887.
53. Khayat, Z. A., Tong, P., Yaworsky, K., Bloch, R. J., Klip, A., Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes. J. Cell. Sci. 2000, 113, 279-290.
54. Caron, J. M., Alteration of microtubule physiology in hepatocytes by insulin. J. Cell. Physiol. 1989, 138, 603-610.